Abstract:Background: Although opioid agonist-based treatments are considered the first-line treatment for opioid use disorders, nonopioid alternatives are urgently needed to combat the inevitable high relapse rates. Compound 511 is a formula derived from ancient traditional Chinese medical literature on opiate rehabilitation. Previously, we observed that Compound 511 could effectively prevent the acquisition of conditioned place preference (CPP) during early morphine exposure. However, its effects on drug-induced reinstatement remain unclear. Purpose: This study aims to estimate the potential of Compound 511 for the therapeutic intervention of opioid relapse in rodent models and explore the potential mechanisms underlying the observed actions.Study design/Methods: The CPP and locomotor sensitization paradigm were established to evaluate the thera-peutic effect of Compound 511 treatment on morphine-induced neuroadaptations, followed by immunofluo-rescence and western blot (WB) analysis of the synaptic markers PSD-95 and Syn-1. Furthermore, several addiction-associated transcription factors and epigenetic marks were examined by qPCR and WB, respectively. Furthermore, the key active ingredients and targets of Compound 511 were further excavated by network pharmacology approach and experimental validation. Results: The results proved that Compound 511 treatment during abstinence blunted both the reinstatement of morphine-evoked CPP and locomotor sensitization, accompanied by the normalization of morphine-induced postsynaptic plasticity in the nucleus accumbens (NAc). Additionally, Compound 511 was shown to exert a selectively repressive influence on morphine-induced hyperacetylation at H3K14 and a reduction in H3K9 dimethylation as well as Delta FosB activation and accumulation in the NAc. Finally, two herbal ingredients of Compound 511 and six putative targets involved in the regulation of histone modification were identified. Conclusion: Our findings indicated that Compound 511 could block CPP reinstatement and locomotor sensiti-zation predominantly via the reversal of morphine-induced postsynaptic plasticity through epigenetic mecha-nisms. Additionally, 1-methoxy-2,3-methylenedioxyxanthone and 1,7-dimethoxyxanthone may serve as key ingredients of Compound 511 by targeting specific epigenetic enzymes. This study provided an efficient non-opioid treatment against opioid addiction.

The Role of HINT1 Protein in Morphine Addiction: an Animal Model‐based Study

Morphine Epigenomically Regulates Behavior Through Alterations in Histone H3 Lysine 9 Dimethylation in the Nucleus Accumbens

The Role of HINT1 in Methamphetamine-Induced Conditioned Place Preference

Shared and Divergent Transcriptomic Regulation in Nucleus Accumbens D1 and D2 Medium Spiny Neurons by Cocaine and Morphine

The Role of HINT1 in Methamphetamine-Induced Behavioral Sensitization

Sirtuin 1 Inhibitor EX527 Suppresses Morphine-Induced Behavioral Sensitization

Role of MEK‐ERK Pathway in Morphine‐induced Conditioned Place Preference in Ventral Tegmental Area of Rats

Study on psychoactive substances addiction in psychopharmacological profiles

Inhibition of Period1 gene attenuates the morphine-induced ERK-CREB activation in frontal cortex, hippocampus, and striatum in mice.

Inhibition of HINT1 Modulates Spinal Nociception and NMDA Evoked Behavior in Mice

Genetic Knockout of the G Protein-Coupled Estrogen Receptor 1 Facilitates the Acquisition of Morphine-Induced Conditioned Place Preference and Aversion in Mice

HINT1 Inhibitors as Selective Modulators of MOR-NMDAR Cross Regulation and Non-Opioid Analgesia

1H NMR-based metabonomic analysis of brain in rats of morphine dependence and withdrawal intervention

Nucleus Accumbens Circuit Disinhibits Lateral Hypothalamus Glutamatergic Neurons Contributing to Morphine Withdrawal Memory in Male Mice

Imbalance of HCN1 and HCN2 Expression in Hippocampal CA1 Area Impairs Spatial Learning and Memory in Rats with Chronic Morphine Exposure.

Upregulation of HCN2 in ventral tegmental area is involved in morphine‐induced conditioned place preference in rats

A novel dopamine D2 receptor-NR2B protein complex might contribute to morphine use disorders

Increased expression of cannabinoid receptor 1 in the nucleus accumbens core in a rat model with morphine withdrawal.

The Role Of Dopamine D1 And D3 Receptors In N-Methyl-D-Aspartate (Nmda)/Glycine(B) Site-Regulated Complex Cognitive Behaviors Following Repeated Morphine Administration

Normalization of the H3K9me2/H3K14ac-FosB pathway in the nucleus accumbens underlying the reversal of morphine-induced behavioural and synaptic plasticity by Compound 511

Proteomic analysis of the nucleus accumbens in rhesus monkeys of morphine dependence and withdrawal intervention.